Optimizing denileukin diftitox (Ontak®) therapy. Hematology Meeting Reports, [S. l.], v. 2, n. 13, 2009. DOI: 10.4081/hmr.v2i13.491. Disponível em: https://journals.pagepress.net/hmr/article/view/491. Acesso em: 28 may. 2026.